Advanced search
Publication Cover
Acta Oto-Laryngologica Volume 133, 2013 - Issue 9
Submit an article Journal homepage
462
Views
12
CrossRef citations to date
0
Altmetric
INNER EAR

Long-term results of intratympanic prednisolone injection in patients with idiopathic sudden sensorineural hearing loss

Roberto FilipoDepartment of Sensory Organs, Sapienza University of Rome, Rome, ItalyCorrespondence[email protected]
,
Giuseppe AttanasioDepartment of Sensory Organs, Sapienza University of Rome, Rome, Italy
,
Laura CagnoniDepartment of Sensory Organs, Sapienza University of Rome, Rome, Italy
,
Eleonora MasciDepartment of Sensory Organs, Sapienza University of Rome, Rome, Italy
,
Francesca Y. RussoDepartment of Sensory Organs, Sapienza University of Rome, Rome, Italy
,
Giulia CartocciDepartment of Sensory Organs, Sapienza University of Rome, Rome, Italy
,
Alessia Di MarioDepartment of Sensory Organs, Sapienza University of Rome, Rome, Italy
&
Edoardo CovelliDepartment of Sensory Organs, Sapienza University of Rome, Rome, Italy
 show all
Pages 900-904 | Received 25 Jan 2013, Accepted 17 Mar 2013, Published online: 22 May 2013

References

  • De Kleyn A. Sudden complete or partial loss of function of the octavus-system in apparently normal persons. Acta Otolaryngol 1944;32:407–29.
  • Byl FM Jr. Sudden hearing loss: eight years' experience and suggested prognostic table. Laryngoscope 1984;94:647–61.
  • Mattox DE, Simmons FB. Natural history of sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol 1977;86:463–80.
  • Wilson WR, Byl FM, Laird N. The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study. Arch Otolaryngol 1980;106:772–6.
  • Wu HP, Chou YF, Yu SH, Wang CP, Hsu CJ, Chen PR. Intratympanic steroid injections as a salvage treatment for sudden sensorineural hearing loss: a randomized, double-blind, placebo-controlled study. Otol Neurotol 2011;32:774–9.
  • Haynes DS, O'Malley M, Cohen S, Watford K, Labadie RF. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. Laryngoscope 2007;117:3–15.
  • Battaglia A, Burchette R, Cueva R. Combination therapy (intratympanic dexamethasone + high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss. Otol Neurotol 2008;29:453–60.
  • Filipo R, Covelli E, Balsamo G, Attanasio G. Intratympanic prednisolone therapy for sudden sensorineural hearing loss: a new protocol. Acta Otolaryngol 2010;130:1209–13.
  • Li P, Zeng XL, Ye J, Yang QT, Zhang GH, Li Y. Intratympanic methylprednisolone improves hearing function in refractory sudden sensorineural hearing loss: a control study. Audiol Neurootol 2011;16:198–202.
  • Dallan I, De Vito A, Fattori B, Casani AP, Panicucci E, Berrettini S, et al. Intratympanic methylprednisolone in refractory sudden hearing loss: a 27-patient case series with univariate and multivariate analysis. Otol Neurotol 2010;31:25–30.
  • Chen CY, Halpin C, Rauch SD. Oral steroid treatment of sudden sensorineural hearing loss: a ten year retrospective analysis. Otol Neurotol 2003;24:728–33.
  • Plontke SK, Löwenheim H, Mertens J, Engel C, Meisner C, Weidner A, et al. Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy. Laryngoscope 2009;119:359–69.
  • Furuhashi A, Matsuda K, Asahi K, Nakashima T. Sudden deafness: long term follow-up and recurrence. Clin Otolaryngol 2002;27:458–63.
  • Siegel LG. The treatment of idiopathic sudden sensorineural hearing loss. Otolaryngol Clin North Am 1975;8:467–73.
  • Filipo R, Attanasio G, Viccaro M, Russo FY, Mancini P, Rocco M, et al. Hyperbaric oxygen therapy with short duration intratympanic steroid therapy for sudden hearing loss. Acta Otolaryngol 2012;132:475–81.
  • Salt AN, Plontke SK. Local inner-ear drug delivery and pharmacokinetics. Drug Discov Today 2005;10:1299–306.
  • Spear SA, Schwartz SR. Intratympanic steroids for sudden sensorineural hearing loss: a systematic review. Otolaryngol Head Neck Surg 2011;145:534–43.
  • Filipo R, Attanasio G, Russo FY, Viccaro M, Mancini P, Covelli E. Intratympanic steroid therapy in moderate sudden hearing loss: a randomized, triple-blind, placebo-controlled trial. Laryngoscope 2013;123:774–8.
  • Rauch SD, Halpin CF, Antonelli PJ, Babu S, Carey JP, Gantz BJ, et al. Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial. JAMA 2011;305:2071–9.
  • Kiliç R, Safak MA, Oğuz H, Kargin S, Demirci M, Samim E, et al. Intratympanic methylprednisolone for sudden sensorineural hearing loss. Otol Neurotol 2007;28:312–16.
  • Nosrati-Zarenoe R, Hultcrantz E. Corticosteroid treatment of idiopathic sudden sensorineural hearing loss: randomized triple-blind placebo-controlled trial. Otol Neurotol 2012;33:523–31.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.